282 related articles for article (PubMed ID: 24944228)
1. Reaching the london declaration on neglected tropical diseases goals for onchocerciasis: an economic evaluation of increasing the frequency of ivermectin treatment in Africa.
Turner HC; Walker M; Churcher TS; Osei-Atweneboana MY; Biritwum NK; Hopkins A; Prichard RK; Basáñez MG
Clin Infect Dis; 2014 Oct; 59(7):923-32. PubMed ID: 24944228
[TBL] [Abstract][Full Text] [Related]
2. The potential impact of moxidectin on onchocerciasis elimination in Africa: an economic evaluation based on the Phase II clinical trial data.
Turner HC; Walker M; Attah SK; Opoku NO; Awadzi K; Kuesel AC; Basáñez MG
Parasit Vectors; 2015 Mar; 8():167. PubMed ID: 25889256
[TBL] [Abstract][Full Text] [Related]
3. Modelling the impact of ivermectin on River Blindness and its burden of morbidity and mortality in African Savannah: EpiOncho projections.
Turner HC; Walker M; Churcher TS; Basáñez MG
Parasit Vectors; 2014 May; 7():241. PubMed ID: 24886747
[TBL] [Abstract][Full Text] [Related]
4. How Can Onchocerciasis Elimination in Africa Be Accelerated? Modeling the Impact of Increased Ivermectin Treatment Frequency and Complementary Vector Control.
Verver S; Walker M; Kim YE; Fobi G; Tekle AH; Zouré HGM; Wanji S; Boakye DA; Kuesel AC; de Vlas SJ; Boussinesq M; Basáñez MG; Stolk WA
Clin Infect Dis; 2018 Jun; 66(suppl_4):S267-S274. PubMed ID: 29860291
[TBL] [Abstract][Full Text] [Related]
5. What does the COVID-19 pandemic mean for the next decade of onchocerciasis control and elimination?
Hamley JID; Blok DJ; Walker M; Milton P; Hopkins AD; Hamill LC; Downs P; de Vlas SJ; Stolk WA; Basáñez MG
Trans R Soc Trop Med Hyg; 2021 Mar; 115(3):269-280. PubMed ID: 33515042
[TBL] [Abstract][Full Text] [Related]
6. Required duration of mass ivermectin treatment for onchocerciasis elimination in Africa: a comparative modelling analysis.
Stolk WA; Walker M; Coffeng LE; Basáñez MG; de Vlas SJ
Parasit Vectors; 2015 Oct; 8():552. PubMed ID: 26489937
[TBL] [Abstract][Full Text] [Related]
7. An Updated Economic Assessment of Moxidectin Treatment Strategies for Onchocerciasis Elimination.
Turner HC; Kura K; Roth B; Kuesel AC; Kinrade S; Basáñez MG
Clin Infect Dis; 2024 Apr; 78(Supplement_2):S138-S145. PubMed ID: 38662693
[TBL] [Abstract][Full Text] [Related]
8. Can mass drug administration of moxidectin accelerate onchocerciasis elimination in Africa?
Kura K; Milton P; Hamley JID; Walker M; Bakajika DK; Kanza EM; Opoku NO; Howard H; Nigo MM; Asare S; Olipoh G; Attah SK; Mambandu GL; Kennedy KK; Kataliko K; Mumbere M; Halleux CM; Hopkins A; Kuesel AC; Kinrade S; Basáñez MG
Philos Trans R Soc Lond B Biol Sci; 2023 Oct; 378(1887):20220277. PubMed ID: 37598705
[TBL] [Abstract][Full Text] [Related]
9. Elimination of transmission of onchocerciasis (river blindness) with long-term ivermectin mass drug administration with or without vector control in sub-Saharan Africa: a systematic review and meta-analysis.
Mutono N; Basáñez MG; James A; Stolk WA; Makori A; Kimani TN; Hollingsworth TD; Vasconcelos A; Dixon MA; de Vlas SJ; Thumbi SM
Lancet Glob Health; 2024 May; 12(5):e771-e782. PubMed ID: 38484745
[TBL] [Abstract][Full Text] [Related]
10. Is onchocerciasis elimination in Africa feasible by 2025: a perspective based on lessons learnt from the African control programmes.
Dadzie Y; Amazigo UV; Boatin BA; Sékétéli A
Infect Dis Poverty; 2018 Jul; 7(1):63. PubMed ID: 29966535
[TBL] [Abstract][Full Text] [Related]
11. Financial and Economic Costs of the Elimination and Eradication of Onchocerciasis (River Blindness) in Africa.
Kim YE; Sicuri E; Tediosi F
PLoS Negl Trop Dis; 2015; 9(9):e0004056. PubMed ID: 26360917
[TBL] [Abstract][Full Text] [Related]
12. Elimination of African onchocerciasis: modeling the impact of increasing the frequency of ivermectin mass treatment.
Coffeng LE; Stolk WA; Hoerauf A; Habbema D; Bakker R; Hopkins AD; de Vlas SJ
PLoS One; 2014; 9(12):e115886. PubMed ID: 25545677
[TBL] [Abstract][Full Text] [Related]
13. Implementation of test-and-treat with doxycycline and temephos ground larviciding as alternative strategies for accelerating onchocerciasis elimination in an area of loiasis co-endemicity: the COUNTDOWN consortium multi-disciplinary study protocol.
Wanji S; Nji TM; Hamill L; Dean L; Ozano K; Njouendou AJ; Abong RA; Obie ED; Amuam A; Ekanya R; Ndongmo WPC; Ndzeshang BL; Fung EG; Nnamdi DB; Nkimbeng DA; Teghen S; Kah E; Piotrowski H; Forrer A; Khan JAM; Woode ME; Niessen L; Watson V; Njoumemi Z; Murdoch ME; Thomson R; Theobald S; Enyong P; Turner JD; Taylor MJ
Parasit Vectors; 2019 Dec; 12(1):574. PubMed ID: 31801631
[TBL] [Abstract][Full Text] [Related]
14. The cost of annual versus biannual community-directed treatment of onchocerciasis with ivermectin: Ghana as a case study.
Turner HC; Osei-Atweneboana MY; Walker M; Tettevi EJ; Churcher TS; Asiedu O; Biritwum NK; Basáñez MG
PLoS Negl Trop Dis; 2013; 7(9):e2452. PubMed ID: 24069497
[TBL] [Abstract][Full Text] [Related]
15. African Programme for Onchocerciasis Control: progress report, 2013-2014.
Wkly Epidemiol Rec; 2014 Dec; 89(49):551-60. PubMed ID: 25485343
[No Abstract] [Full Text] [Related]
16. Uncertainty surrounding projections of the long-term impact of ivermectin treatment on human onchocerciasis.
Turner HC; Churcher TS; Walker M; Osei-Atweneboana MY; Prichard RK; Basáñez MG
PLoS Negl Trop Dis; 2013; 7(4):e2169. PubMed ID: 23634234
[TBL] [Abstract][Full Text] [Related]
17. Modelling the elimination of river blindness using long-term epidemiological and programmatic data from Mali and Senegal.
Walker M; Stolk WA; Dixon MA; Bottomley C; Diawara L; Traoré MO; de Vlas SJ; Basáñez MG
Epidemics; 2017 Mar; 18():4-15. PubMed ID: 28279455
[TBL] [Abstract][Full Text] [Related]
18. Can ivermectin mass treatments eliminate onchocerciasis in Africa?
Winnen M; Plaisier AP; Alley ES; Nagelkerke NJ; van Oortmarssen G; Boatin BA; Habbema JD
Bull World Health Organ; 2002; 80(5):384-91. PubMed ID: 12077614
[TBL] [Abstract][Full Text] [Related]
19. Alternative treatment strategies to accelerate the elimination of onchocerciasis.
Boussinesq M; Fobi G; Kuesel AC
Int Health; 2018 Mar; 10(suppl_1):i40-i48. PubMed ID: 29471342
[TBL] [Abstract][Full Text] [Related]
20. African Programme For Onchocerciasis Control 1995-2015: model-estimated health impact and cost.
Coffeng LE; Stolk WA; Zouré HG; Veerman JL; Agblewonu KB; Murdoch ME; Noma M; Fobi G; Richardus JH; Bundy DA; Habbema D; de Vlas SJ; Amazigo UV
PLoS Negl Trop Dis; 2013; 7(1):e2032. PubMed ID: 23383355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
